Literature DB >> 3801435

Testing the two-state model: anomalous effector binding to human hemoglobin.

M C Marden, E S Hazard, Q H Gibson.   

Abstract

Three allosteric states are required to describe the relaxation of (carbon monoxy) hemoglobin following flash photolysis. Combined absorbance and fluorescence probes were used. The absorbance signals consist of a component corresponding to ligand recombination and a component for the R-T transition. The fluorescence of 8-hydroxy-1,3,6-pyrenetrisulfonate (HPT), an analogue of 2,3-diphosphoglycerate, shows rates and amplitudes correlated with the absorbance transients. Measurements were made at pII 6, 6.5, and 7.0 at CO partial pressures of 0.1 and 1 atm. The fractional photolysis was varied in each case to change the initial distribution of the R states. Data show an immediate absorbance change due to ligand dissociation, while the changes in the ligand isosbestic and the fluorescence signals occur with time constants of 80 microseconds (at pH 6.5). The signals then show a biphasic return to equilibrium, characteristic of the allosteric system. The measurements provide three independent probes of the kinetics of the substates of hemoglobin. Although the ligand binding data can be generally represented by a two-state model, the fluorescence data require T states with different affinities for HPT.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801435     DOI: 10.1021/bi00371a049

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Heterotropic effectors exert more significant strain on monoligated than on unligated hemoglobin.

Authors:  M Coletta; M Angeletti; I Ascone; G Boumis; A C Castellano; M Dell'Ariccia; S Della Longa; G De Sanctis; A M Priori; R Santucci; A Feis; G Amiconi
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

2.  Application of linear free energy relations to protein conformational changes: the quaternary structural change of hemoglobin.

Authors:  W A Eaton; E R Henry; J Hofrichter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Quaternary structure dynamics and carbon monoxide binding kinetics of hemoglobin valency hybrids.

Authors:  J S Philo; U Dreyer; J W Lary
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

4.  A two-state analysis of co-operative oxygen binding in the three human embryonic haemoglobins.

Authors:  T Brittain; O M Hofmann; N J Watmough; C Greenwood; R E Weber
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

5.  Photoselection in polarized photolysis experiments on heme proteins.

Authors:  A Ansari; C M Jones; E R Henry; J Hofrichter; W A Eaton
Journal:  Biophys J       Date:  1993-03       Impact factor: 4.033

6.  Control of the allosteric equilibrium of hemoglobin by cross-linking agents.

Authors:  Michael C Marden; Marion Cabanes-Macheteau; Alexandru Babes; Laurent Kiger; Nathalie Griffon; Claude Poyart; Telih Boyiri; Martin K Safo; Donald J Abraham
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

7.  Rate of allosteric change in hemoglobin measured by modulated excitation using fluorescence detection.

Authors:  A J Martino; F A Ferrone
Journal:  Biophys J       Date:  1989-10       Impact factor: 4.033

8.  Allosteric kinetics and equilibria of triligated, cross-linked hemoglobin.

Authors:  M Zhao; J Jiang; M Greene; M E Andracki; S A Fowler; J A Walder; F A Ferrone
Journal:  Biophys J       Date:  1993-05       Impact factor: 4.033

9.  Oxygen and CO binding to triply NO and asymmetric NO/CO hemoglobin hybrids.

Authors:  L Kiger; C Poyart; M C Marden
Journal:  Biophys J       Date:  1993-09       Impact factor: 4.033

10.  MWC allosteric model explains unusual hemoglobin-oxygen binding curves from sickle cell drug binding.

Authors:  Eric R Henry; Julia Harper; Kristen E Glass; Belhu Metaferia; John M Louis; William A Eaton
Journal:  Biophys J       Date:  2021-04-29       Impact factor: 3.699

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.